Lilly completes biopharma acquisitions

Eli Lilly and Company has completed acquisition of two biopharmaceutical companies – Versanis Bio and Sigilon Therapeutics - and their lead assets focused on obesity and diabetes.
Lilly announced...
-Today at 06:31 pm- MarketScreener

Related Keywords

China ,United States ,Canada ,France ,Japan ,United Kingdom ,Mt Cantor Fitzgerald ,Ruth Gimeno ,Aboutsurperformance Sasabout ,Nederlands Nederland ,M Eli Lilly ,Europe America Asia ,Mt Morgan Stanley ,Versanis Bio ,Deutsch Deutschland ,Mt Goldman Sachs ,Mt Eli Lilly ,Deutsch Schweiz ,Nederlands Belgi ,Eli Lilly ,Novo Nordisk ,Eli Lilly And Company ,B Other Pharmaceuticals ,Company Profile Eli Lilly ,Medicxi Ventures United Kingdom ,Sony ,Russell Publishing ,Flagship Ventures Fund ,Sector Pharmaceuticals Calendar ,Company Durationauto ,Versanis Bio Inc ,First Trillion Dollar Healthcare Company Aug ,Allianz ,Sigilon Therapeutics Inc ,Flagship Pioneering Special Opportunities Fund ,Mt Wolfe Research Adjusts Eli Lilly Price ,Company Trading Rating ,Disney ,Sector Other Pharmaceuticals ,European Pharmaceutical ,Russell Publishing Limited ,Trade Journals Share ,Eli Lilly Closes ,Lilly Completes Purchase ,Sigilon Therapeutics ,Cash Deal ,Lilly Completes Acquisition ,Lilly Plans Over ,Become First Trillion Dollar Healthcare Company ,Medicxi Ventures ,Down Weekly ,Prices Moved Modestly Higher ,Materials Weigh ,Flagship Pioneering ,Develop Diagnostics System ,Identify Therapy Eligible Lung Cancer Patients ,Lilly Gets Price Target Increases ,Lilly Wraps Up Acquisition ,Dice Therapeutics ,Adjusts Eli Lilly Price Target ,Maintains Overweight Rating ,Fargo Adjusts Eli Lilly Price Target ,Fitzgerald Adjusts Eli Lilly Price Target ,Securities Adjusts Eli Lilly Price Target ,Maintains Buy Rating ,Suisse Adjusts Eli Lilly Price Target ,Maintains Outperform Rating ,Stanley Adjusts Eli Lilly Price Target ,Research Adjusts Eli Lilly Price Target ,Sachs Raises Eli Lilly Price Target ,Maintains Neutral Rating ,Max Perioddayweek ,Company Profile ,Income Statement Evolution ,Trading Rating ,Investor Rating ,More Ratings ,Analyst Consensus ,Close Price ,More Indexes ,More Top ,Virtual Portfoliosnewsletters ,Markets ,